Dying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity

Immunity

Volumn 35, Issue 4, 2011, Pages 478-490

  Yatim, Nader ^a   Albert, Matthew L ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYTOCHROME C; DEATH RECEPTOR; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TOLL LIKE RECEPTOR 7;

APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CELL CYCLE; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOMEGALOVIRUS INFECTION; CYTOSKELETON; DENDRITIC CELL; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; ENDOSOME; GENE CONTROL; HUMAN; IMMUNE RESPONSE; IMMUNOSENSOR; INFLAMMATION; INFLUENZA A; INNATE IMMUNITY; LATENT VIRUS INFECTION; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; REVIEW; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS TRANSMISSION;

ANIMALS; AUTOPHAGY; BIOLOGICAL EVOLUTION; CELL DEATH; HUMANS; IMMUNE SYSTEM; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUS REPLICATION;

EID: 80755155767     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.10.010     Document Type: Review

References (113)

1. Accapezzato D., Visco V., Francavilla V., Molette C., Donato T., Paroli M., Mondelli M.U., Doria M., Torrisi M.R., Barnaba V. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J. Exp. Med. 2005, 202:817-828.
2. Albert M.L. Death-defying immunity: Do apoptotic cells influence antigen processing and presentation?. Nat. Rev. Immunol. 2004, 4:223-231.
3. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998, 188:1359-1368.
4. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
5. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
6. Ameisen J.C. Looking for death at the core of life in the light of evolution. Cell Death Differ. 2004, 11:4-10.
7. Andreansky S.S., Stambas J., Thomas P.G., Xie W., Webby R.J., Doherty P.C. Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J. Virol. 2005, 79:4329-4339.
8. Arkhipova I., Meselson M. Deleterious transposable elements and the extinction of asexuals. Bioessays 2005, 27:76-85.
9. Arnoult D., Bartle L.M., Skaletskaya A., Poncet D., Zamzami N., Park P.U., Sharpe J., Youle R.J., Goldmacher V.S. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. USA 2004, 101:7988-7993.
10. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, Cambridge University Press, Cambridge. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley, K. Yamanishi (Eds.).
11. Barreiro L.B., Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 2010, 11:17-30.
12. Bender A., Albert M., Reddy A., Feldman M., Sauter B., Kaplan G., Hellman W., Bhardwaj N. The distinctive features of influenza virus infection of dendritic cells. Immunobiology 1998, 198:552-567.
13. Bergmann M., Garcia-Sastre A., Carnero E., Pehamberger H., Wolff K., Palese P., Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 2000, 74:6203-6206.
14. Influenza Report 2006, Druckhaus Sud GmbH, Cologne. B.S. Kamps, C. Hoffman, W. Presier (Eds.).
15. Blachère N.E., Darnell R.B., Albert M.L. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol. 2005, 3:e185.
16. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 2006, 177:7094-7102.
17. Britt W. Virus entry into host, establishment of infection, spread in host. Human Herpesviruses 2007, Cambridge University Press, Cambridge. T. Biology, A.A. Immunoprophylaxis, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley, K. Yamanishi (Eds.).
18. Brune W. Inhibition of programmed cell death by cytomegaloviruses. Virus Res. 2011, 157:144-150.
19. Brune W., Ménard C., Heesemann J., Koszinowski U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001, 291:303-305.
20. Brune W., Nevels M., Shenk T. Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J. Virol. 2003, 77:11633-11643.
21. Cam M., Handke W., Picard-Maureau M., Brune W. Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins. Cell Death Differ. 2010, 17:655-665.
22. Carlson C.M., Turpin E.A., Moser L.A., O'Brien K.B., Cline T.D., Jones J.C., Tumpey T.M., Katz J.M., Kelley L.A., Gauldie J., Schultz-Cherry S. Transforming growth factor-β: Activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog. 2010, 6:e1001136.
23. Casarosa P., Bakker R.A., Verzijl D., Navis M., Timmerman H., Leurs R., Smit M.J. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem. 2001, 276:1133-1137.
24. Chanturiya A.N., Basañez G., Schubert U., Henklein P., Yewdell J.W., Zimmerberg J. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 2004, 78:6304-6312.
25. Chattopadhyay S., Marques J.T., Yamashita M., Peters K.L., Smith K., Desai A., Williams B.R., Sen G.C. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 2010, 29:1762-1773.
26. Chen W., Calvo P.A., Malide D., Gibbs J., Schubert U., Bacik I., Basta S., O'Neill R., Schickli J., Palese P., et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 2001, 7:1306-1312.
27. Chen W., Norbury C.C., Cho Y., Yewdell J.W., Bennink J.R. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 2001, 193:1319-1326.
28. Chera S., Buzgariu W., Ghila L., Galliot B. Autophagy in Hydra: A response to starvation and stress in early animal evolution. Biochim. Biophys. Acta 2009, 1793:1432-1443.
29. Cicin-Sain L., Ruzsics Z., Podlech J., Bubić I., Menard C., Jonjić S., Reddehase M.J., Koszinowski U.H. Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J. Virol. 2008, 82:2056-2064.
30. Coleman J.R. The PB1-F2 protein of Influenza A virus: Increasing pathogenicity by disrupting alveolar macrophages. Virol. J. 2007, 4:9.
31. Correia-Silva Jde.F., Victória J.M., Guimarães A.L., Salomão U.E., de Abreu M.H., Bittencourt H., Gomez R.S. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients. Oral Dis. 2007, 13:163-169.
32. Crowe S.R., Miller S.C., Woodland D.L. Identification of protective and non-protective T cell epitopes in influenza. Vaccine 2006, 24:452-456.
33. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., Biron C.A. Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003, 197:885-898.
34. DeFilippis V.R., Alvarado D., Sali T., Rothenburg S., Früh K. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J. Virol. 2010, 84:585-598.
35. de la Calle C., Joubert P.E., Law H.K., Hasan M., Albert M.L. Simultaneous assessment of autophagy and apoptosis using multispectral imaging cytometry. Autophagy 2011, 7:1045-1051.
36. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
37. Downward J. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 2004, 15:177-182.
38. Edelmann K.H., Richardson-Burns S., Alexopoulou L., Tyler K.L., Flavell R.A., Oldstone M.B. Does Toll-like receptor 3 play a biological role in virus infections?. Virology 2004, 322:231-238.
39. Ehrhardt C., Ludwig S. A new player in a deadly game: Influenza viruses and the PI3K/Akt signalling pathway. Cell. Microbiol. 2009, 11:863-871.
40. Ehrhardt C., Wolff T., Ludwig S. Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. J. Virol. 2007, 81:12097-12100.
41. Ehrhardt C., Wolff T., Pleschka S., Planz O., Beermann W., Bode J.G., Schmolke M., Ludwig S. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 2007, 81:3058-3067.
42. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., Cain K., MacFarlane M., Häcker G., Leverkus M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43:449-463.
43. Fugmann S.D. The origins of the Rag genes-from transposition to V(D)J recombination. Semin. Immunol. 2010, 22:10-16.
44. Gannagé M., Dormann D., Albrecht R., Dengjel J., Torossi T., Rämer P.C., Lee M., Strowig T., Arrey F., Conenello G., et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 2009, 6:367-380.
45. Giodini A., Albert M.L. A whodunit: An appointment with death. Curr. Opin. Immunol. 2010, 22:94-108.
46. Green D.R. The end and after: How dying cells impact the living organism. Immunity 2011, 35:441-444. this issue.
47. Green D.R., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 2009, 9:353-363.
48. Hedrick S.M. The acquired immune system: A vantage from beneath. Immunity 2004, 21:607-615.
49. Hengel H., Koszinowski U.H., Conzelmann K.K. Viruses know it all: New insights into IFN networks. Trends Immunol. 2005, 26:396-401.
50. Herold S., Steinmueller M., von Wulffen W., Cakarova L., Pinto R., Pleschka S., Mack M., Kuziel W.A., Corazza N., Brunner T., et al. Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205:3065-3077.
51. Holtappels R., Podlech J., Pahl-Seibert M.F., Jülch M., Thomas D., Simon C.O., Wagner M., Reddehase M.J. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J. Exp. Med. 2004, 199:131-136.
52. Ibanez C.E., Schrier R., Ghazal P., Wiley C., Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 1991, 65:6581-6588.
53. Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
54. Ichinohe T., Pang I.K., Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010, 11:404-410.
55. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 2011, 108:5354-5359.
56. Jounai N., Takeshita F., Kobiyama K., Sawano A., Miyawaki A., Xin K.Q., Ishii K.J., Kawai T., Akira S., Suzuki K., Okuda K. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl. Acad. Sci. USA 2007, 104:14050-14055.
57. Jurak I., Schumacher U., Simic H., Voigt S., Brune W. Murine cytomegalovirus m38.5 protein inhibits Bax-mediated cell death. J. Virol. 2008, 82:4812-4822.
58. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., Caspary T., Mocarski E.S. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
59. Kang R., Zeh H.J., Lotze M.T., Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18:571-580.
60. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
61. Kijpittayarit S., Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin. Infect. Dis. 2007, 44:1315-1320.
62. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21:107-119.
63. Lagunoff M., Carroll P.A. Inhibition of apoptosis by the gamma-herpesviruses. Int. Rev. Immunol. 2003, 22:373-399.
64. Lamkanfi M., Dixit V.M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 2010, 8:44-54.
65. Lederberg J. J. B. S. Haldane (1949) on infectious disease and evolution. Genetics 1999, 153:1-3.
66. Lederberg J. Infectious history. Science 2000, 288:287-293.
67. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007, 315:1398-1401.
68. Loureiro J., Ploegh H.L. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv. Immunol. 2006, 92:225-305.
69. Mack C., Sickmann A., Lembo D., Brune W. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc. Natl. Acad. Sci. USA 2008, 105:3094-3099.
70. Mackey D., McFall A.J. MAMPs and MIMPs: Proposed classifications for inducers of innate immunity. Mol. Microbiol. 2006, 61:1365-1371.
71. McAuley J.L., Chipuk J.E., Boyd K.L., Van De Velde N., Green D.R., McCullers J.A. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 2010, 6:e1001014.
72. McCormick A.L., Meiering C.D., Smith G.B., Mocarski E.S. Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J. Virol. 2005, 79:12205-12217.
73. McCormick A.L., Roback L., Mocarski E.S. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog. 2008, 4:e1000063.
74. McCormick A.L., Roback L., Livingston-Rosanoff D., St Clair C. The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J. Virol. 2010, 84:5108-5123.
75. McLean J.E., Datan E., Matassov D., Zakeri Z.F. Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J. Virol. 2009, 83:8233-8246.
76. Ménard C., Wagner M., Ruzsics Z., Holak K., Brune W., Campbell A.E., Koszinowski U.H. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol. 2003, 77:5557-5570.
77. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 2004, 5:503-507.
78. Mibayashi M., Martínez-Sobrido L., Loo Y.M., Cárdenas W.B., Gale M., García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 2007, 81:514-524.
79. Michallet M.C., Meylan E., Ermolaeva M.A., Vazquez J., Rebsamen M., Curran J., Poeck H., Bscheider M., Hartmann G., König M., et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 2008, 28:651-661.
80. Miller-Kittrell M., Sparer T.E. Feeling manipulated: Cytomegalovirus immune manipulation. Virol. J. 2009, 6:4.
81. Mocarski E.S. Immune escape and exploitation strategies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system. Cell. Microbiol. 2004, 6:707-717.
82. Mochizuki A., Yahara K., Kobayashi I., Iwasa Y. Genetic addiction: Selfish gene's strategy for symbiosis in the genome. Genetics 2006, 172:1309-1323.
83. Munks M.W., Cho K.S., Pinto A.K., Sierro S., Klenerman P., Hill A.B. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J. Immunol. 2006, 177:450-458.
84. Nencioni L., De Chiara G., Sgarbanti R., Amatore D., Aquilano K., Marcocci M.E., Serafino A., Torcia M., Cozzolino F., Ciriolo M.R., et al. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: Impact on virally induced apoptosis and viral replication. J. Biol. Chem. 2009, 284:16004-16015.
85. Nosek J., Kosa P., Tomaska L. On the origin of telomeres: A glimpse at the pre-telomerase world. Bioessays 2006, 28:182-190.
86. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
87. Poole E., King C.A., Sinclair J.H., Alcami A. The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J. 2006, 25:4390-4399.
88. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., Vanaja S.K., Monks B.G., Ganesan S., Latz E., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11:395-402.
89. Rebsamen M., Heinz L.X., Meylan E., Michallet M.C., Schroder K., Hofmann K., Vazquez J., Benedict C.A., Tschopp J. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep. 2009, 10:916-922.
90. Rivett A.J., Hearn A.R. Proteasome function in antigen presentation: Immunoproteasome complexes, Peptide production, and interactions with viral proteins. Curr. Protein Pept. Sci. 2004, 5:153-161.
91. Rossman J.S., Lamb R.A. Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe 2009, 6:299-300.
92. Schultz-Cherry S., Hinshaw V.S. Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 1996, 70:8624-8629.
93. Seong S.Y., Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.
94. Simon C.O., Holtappels R., Tervo H.M., Böhm V., Däubner T., Oehrlein-Karpi S.A., Kühnapfel B., Renzaho A., Strand D., Podlech J., et al. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 2006, 80:10436-10456.
95. Skaletskaya A., Bartle L.M., Chittenden T., McCormick A.L., Mocarski E.S., Goldmacher V.S. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 2001, 98:7829-7834.
96. Slobedman B., Cao J.Z., Avdic S., Webster B., McAllery S., Cheung A.K., Tan J.C., Abendroth A. Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol. 2010, 5:883-900.
97. Stasakova J., Ferko B., Kittel C., Sereinig S., Romanova J., Katinger H., Egorov A. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J. Gen. Virol. 2005, 86:185-195.
98. Szomolanyi-Tsuda E., Liang X., Welsh R.M., Kurt-Jones E.A., Finberg R.W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 2006, 80:4286-4291.
99. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2004, 101:3516-3521.
100. Tait S.W., Green D.R. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11:621-632.
101. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
102. Tomkinson A., Tepper J., Morton M., Bowden A., Stevens L., Harris P., Lindell D., Fitch N., Gundel R., Getz E.B. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma. Allergy 2010, 65:69-77.
103. Uhl M., Kepp O., Jusforgues-Saklani H., Vicencio J.M., Kroemer G., Albert M.L. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ. 2009, 16:991-1005.
104. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:302-313.
105. Varga Z.T., Ramos I., Hai R., Schmolke M., García-Sastre A., Fernandez-Sesma A., Palese P. The influenza virus protein PB1-F2 inhibits the induction of type i interferon at the level of the MAVS adaptor protein. PLoS Pathog. 2011, 7:e1002067.
106. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
107. Wurzer W.J., Planz O., Ehrhardt C., Giner M., Silberzahn T., Pleschka S., Ludwig S. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 2003, 22:2717-2728.
108. Yutin N., Wolf M.Y., Wolf Y.I., Koonin E.V. The origins of phagocytosis and eukaryogenesis. Biol. Direct 2009, 4:9.
109. Zamarin D., García-Sastre A., Xiao X., Wang R., Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 2005, 1:e4.
110. Zamarin D., Ortigoza M.B., Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 2006, 80:7976-7983.
111. Zell R., Krumbholz A., Eitner A., Krieg R., Halbhuber K.J., Wutzler P. Prevalence of PB1-F2 of influenza A viruses. J. Gen. Virol. 2007, 88:536-546.
112. Zhirnov O.P., Klenk H.D. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis 2007, 12:1419-1432.
113. Ziegler H., Muranyi W., Burgert H.G., Kremmer E., Koszinowski U.H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 2000, 19:870-881.